Over the past several years, Accelerate Diagnostics and our scientific collaborators have conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.Okay, I understand. Show me the publications.
Improving Outcomes and Antibiotic Stewardship for patients with bloodstream Infections (IOAS): a quasiexperimental multi-centre analysis of time to optimal therapy
Amira Bhalodi, Shawn Macvane, Margie Morgan, et al. (Cedars-Sinai Medical Center, UAMS - University of Arkansas for Medical Sciences, University of Iowa Hospitals & Clinics, Accelerate Diagnostics)
Using the Antibiotic Spectrum Index (ASI) score to assess antibiotic exposure for patients with Bloodstream Infections (BSI): an analysis of the Accelerate PhenoTest BC Kit (AXDX) IOAS study
Shawn Macvane, Amira Bhalodi, Margie Morgan, et al. (Cedars-Sinai Medical Center, UAMS - University of Arkansas for Medical Sciences, University of Iowa Hospitals & Clinics, Accelerate Diagnostics)
Turnaround time for pathogen identification and antimicrobial susceptibility testing of bronchoalveolar lavage specimens in U.S. acute care hospitals
Shawn Macvane, Niels Oppermann, Romney Humphries (Accelerate Diagnostics)
The effectiveness of two rapid identification technologies in Gram-negative bacteraemia without antimicrobial stewardship interventions
Lee Nguyen, Donna Chong, Jenee Vo, et al. (Loma Linda University)
Evaluation of a new tool in diagnostic process of sepsis: reporting results to a smartphone
Nelly Daniela Zurita Cruz, Arturo Manuel Fraile Torres, Tamara Soler Maniega, et al. (Hospital Universitario de La Princesa)
Accelerate Pheno™ System in Sepsis by Gram-negative Pathogens: Four Months of Hospital Experience
Giuseppe V De Socio, Alessandra Belati, Riccardo Paggi, et al. ( Perugia General Hospital, University of Perugia)
Improving Outcomes and Antibiotic Stewardship for Patients with Bacteremia (IOAS): A Quasi-Experimental Multicenter Analysis of Time to Optimal Therapy
Texas Medical Center Antimicrobial Resistance and Stewardship Conference 2020
Bhalodi AA, MacVane SH, Morgan MA, Ben-Aderet MA, Madhusudhan M, Kolev J, Dare RK, Rosenbaum E, Wolfe K, Ford B, Ince D, Kinn PM, Percival KM, Humphries RM (Cedars-Sinai Medical Center, University of Arkansas for Medical Sciences, University of Iowa, Accelerate Diagnostics)
Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system
European Journal of Clinical Microbiology & Infectious Diseases
Ullberg M, Özenci V (Karolinska Institutet, Karolinska University Hospital)
Rapid Microbial Identification and Phenotypic Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures: A New Platform Compared to Routine Laboratory Methods
Diagnostic Microbiology and Infectious Disease
Adriana Calderaro, Mirko Buttrini, Monica Martinelli, et al. (University of Parma, Italy)
Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with Gram-negative bloodstream infections
BMC Infectious Diseases
Gerald Elliott, Michael Malczynski, Viktorjia O. Barr, Doaa Aljefri, David Martin, Sarah Sutton, Teresa R. Zembower, Michael Postelnick, Chao Qi (Northwestern Memorial Hospital)